Hull M - Search Results

1

Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.

Kim HN, Newcomb CW, Carbonari DM, Roy JA, Torgersen J, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Sun J, Hull M, Gill MJ, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Lo Re V 3rd; North American AIDS Cohort Collaboration on Research, Design of IeDEA. Kim HN, et al. Among authors: hull m. Hepatology. 2021 Sep;74(3):1190-1202. doi: 10.1002/hep.31839. Epub 2021 Jun 22. Hepatology. 2021. PMID: 33780007 Free PMC article.

2

Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals.

Klein MB, Rollet KC, Hull M, Cooper C, Walmsley S, Conway B, Pick N; Canadian Co-infection Cohort Study (CTN222) Investigators. Klein MB, et al. Among authors: hull m. Antivir Ther. 2013;18(5):717-21. doi: 10.3851/IMP2484. Epub 2012 Dec 4. Antivir Ther. 2013. PMID: 23211632

3

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.

Hull M, Klein M, Shafran S, Tseng A, Giguère P, Côté P, Poliquin M, Cooper C. Hull M, et al. Can J Infect Dis Med Microbiol. 2013 Winter;24(4):217-38. doi: 10.1155/2013/781410. Can J Infect Dis Med Microbiol. 2013. PMID: 24489565 Free PMC article.

4

Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.

Cox J, Maurais E, Hu L, Moodie EE, Law S, Bozinoff N, Potter M, Rollet K, Hull M, Tyndall M, Cooper C, Gill J, Saeed S, Klein MB; Canadian Co-infection Cohort (CTN 222). Cox J, et al. Among authors: hull m. Drug Alcohol Depend. 2014 Apr 1;137:121-8. doi: 10.1016/j.drugalcdep.2014.01.014. Epub 2014 Jan 30. Drug Alcohol Depend. 2014. PMID: 24559606

5

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.

Cooper C, Rollet-Kurhajec KC, Young J, Vasquez C, Tyndall M, Gill J, Pick N, Walmsley S, Klein MB; Canadian Co-infection Cohort Study Investigators. Cooper C, et al. HIV Med. 2015 Jan;16(1):24-31. doi: 10.1111/hiv.12168. Epub 2014 May 18. HIV Med. 2015. PMID: 24837567 Free PMC article.

6

Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study.

Young J, Potter M, Cox J, Cooper C, Gill J, Hull M, Walmsley S, Klein MB. Young J, et al. Among authors: hull m. CMAJ Open. 2013 Sep 24;1(3):E106-14. doi: 10.9778/cmajo.20130009. eCollection 2013 Sep. CMAJ Open. 2013. PMID: 25077109 Free PMC article.

7

Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.

Klein MB, Lee T, Brouillette MJ, Sheehan NL, Walmsley S, Wong DK, Conway B, Hull M, Cooper C, Haidar S, Vezina S, Annable L, Young S, Zubyk W, Singer J. Klein MB, et al. Among authors: hull m. HIV Clin Trials. 2014 Jul-Aug;15(4):161-75. doi: 10.1310/hct1504-161. HIV Clin Trials. 2014. PMID: 25143025 Clinical Trial.

8

CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults.

Hull M, Shafran S, Tseng A, Giguère P, Klein MB, Cooper C. Hull M, et al. Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):311-20. doi: 10.1155/2014/251989. Can J Infect Dis Med Microbiol. 2014. PMID: 25587293 Free PMC article.

9

Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.

Moqueet N, Infante-Rivard C, Platt RW, Young J, Cooper C, Hull M, Walmsley S, Klein MB; Canadian Co-Infection Study Investigators. Moqueet N, et al. Among authors: hull m. Int J Mol Sci. 2015 Mar 20;16(3):6496-512. doi: 10.3390/ijms16036496. Int J Mol Sci. 2015. PMID: 25803108 Free PMC article.

10

Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.

Yeung MW, Young J, Moodie E, Rollet-Kurhajec KC, Schwartzman K, Greenaway C, Cooper C, Cox J, Gill J, Hull M, Walmsley S, Klein MB. Yeung MW, et al. Among authors: hull m. HIV Clin Trials. 2015 May-Jun;16(3):100-10. doi: 10.1179/501100000024. Epub 2015 May 14. HIV Clin Trials. 2015. PMID: 25972048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,402 results

Search Page